CD4 and acute lymphoblastic leukemia: Furthermore, a molecular characterization of the cellular content in these tumours showed a majority (70%) of double positive CD4+ CD8+ T-cell tumours (Fig. 2c, Supplementary Fig. 2b), consistent with the reported T-ALL predisposition.